These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pulmonary surfactant in neonatal pathology]. Artus JC; Benezech C; Llory J; Bonnet H; Lesbros D Ann Anesthesiol Fr; 1976; 17(1):19-28. PubMed ID: 990049 [TBL] [Abstract][Full Text] [Related]
3. Effect of Pasteurella haemolytica (A1) capsular polysaccharide on sheep lung in vivo and on pulmonary surfactant in vitro. Brogden KA; Adlam C; Lehmkuhl HD; Cutlip RC; Knights JM; Engen RL Am J Vet Res; 1989 Apr; 50(4):555-9. PubMed ID: 2712422 [TBL] [Abstract][Full Text] [Related]
4. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. Günther A; Balser M; Schmidt R; Markart P; Olk A; Börgermann J; Splittgerber FH; Seeger W; Friedrich I J Thorac Cardiovasc Surg; 2004 Feb; 127(2):344-54. PubMed ID: 14762341 [TBL] [Abstract][Full Text] [Related]
5. Postmortem changes in the surpellic activity of lung surfactant. Pattle RE; Cooper SM Br J Exp Pathol; 1978 Aug; 59(4):337-8. PubMed ID: 581349 [TBL] [Abstract][Full Text] [Related]
7. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins. Friedrich W; Schmalisch G; Stevens PA; Wauer RR Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187 [TBL] [Abstract][Full Text] [Related]
8. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome]. Silberg IE; Grønn M Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1456-8. PubMed ID: 9198922 [TBL] [Abstract][Full Text] [Related]
9. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. Friedrich I; Börgermann J; Splittgerber FH; Brinkmann M; Reidemeister JC; Silber RE; Seeger W; Schmidt R; Günther A J Thorac Cardiovasc Surg; 2004 Feb; 127(2):335-43. PubMed ID: 14762340 [TBL] [Abstract][Full Text] [Related]
10. Protein leaks and surfactant dysfunction in the pathogenesis of respiratory distress syndrome. Jobe A Eur Respir J Suppl; 1989 Mar; 3():27s-32s. PubMed ID: 2742683 [TBL] [Abstract][Full Text] [Related]
11. Bilirubin influence on oxidative lung damage and surfactant surface tension properties. Dani C; Martelli E; Tronchin M; Buonocore G; Longini M; Di Filippo A; Giossi M; Rubaltelli FF Pediatr Pulmonol; 2004 Sep; 38(3):179-85. PubMed ID: 15274094 [TBL] [Abstract][Full Text] [Related]
12. [The mucociliary system of the lung--role of surfactants]. Gehr P; Im Hof V; Geiser M; Schürch S Schweiz Med Wochenschr; 2000 May; 130(19):691-8. PubMed ID: 10846763 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between the pathomorphological characteristics of the lungs and surfactant properties in some forms of chronic pneumonia]. Nesterov EN; Panevskaia GN; Kobozev GV Arkh Patol; 1978; 40(3):54-8. PubMed ID: 580566 [TBL] [Abstract][Full Text] [Related]
14. [Effect of oxygen and hypergravitation on alveolar surfactant]. Tikhonov MA; Petrov OV; Kondakov AV; Loginova EV Biull Eksp Biol Med; 1978; 86(7):24-7. PubMed ID: 581062 [TBL] [Abstract][Full Text] [Related]
15. Studies of factors influencing lung stability: biochemical changes of pulmonary surfactant and morphological changes of terminal air spaces in the developing rat. Suzuki Y; Tabata R; Okawa KI Jpn J Exp Med; 1978 Aug; 48(4):345-53. PubMed ID: 581391 [TBL] [Abstract][Full Text] [Related]
16. Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment. de Winter JP; Merth IT; van Bel F; Egberts J; Brand R; Quanjer PH Pediatr Res; 1994 May; 35(5):541-9. PubMed ID: 8065835 [TBL] [Abstract][Full Text] [Related]
17. Modulation of pulmonary defense mechanisms against viral and bacterial infections by acute exposures to nitrogen dioxide. Jakab GJ Res Rep Health Eff Inst; 1988 Nov; (20):1-38. PubMed ID: 2855873 [TBL] [Abstract][Full Text] [Related]
18. [Presence of the surfactant system in the lung as a condition for recovery from upper respiratory tract diseases. I. Introduction]. Wildeboer-Venema FN Ned Tijdschr Geneeskd; 1971 Aug; 115(35):1455-9. PubMed ID: 5109314 [No Abstract] [Full Text] [Related]